The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
Fool.com Headlines
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
TipRanks
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago

Enbridge Inc. (TSE:ENB) Given Average Recommendation of "Moderate Buy" by Brokerages

MarketBeat
30 days ago

Trane Technologies plc (NYSE:TT) Receives Consensus Rating of "Moderate Buy" from Analysts

MarketBeat
30 days ago

Global-e Online Ltd. (NASDAQ:GLBE) Given Average Recommendation of "Moderate Buy" by Analysts

MarketBeat
30 days ago

Cardinal Health, Inc. (NYSE:CAH) Given Average Recommendation of "Moderate Buy" by Analysts

MarketBeat
30 days ago

Arhaus, Inc. (NASDAQ:ARHS) Given Average Rating of "Hold" by Brokerages

MarketBeat
30 days ago

TechnipFMC plc (NYSE:FTI) Given Average Recommendation of "Moderate Buy" by Brokerages

MarketBeat
30 days ago

Penumbra, Inc. (NYSE:PEN) Receives Average Rating of "Hold" from Analysts

MarketBeat
30 days ago

Marathon Digital Holdings, Inc. (NASDAQ:MARA) Receives Average Recommendation of "Moderate Buy" from Analysts

MarketBeat
30 days ago

Philip Morris International Inc. (NYSE:PM) Given Average Recommendation of "Moderate Buy" by Analysts

MarketBeat
30 days ago

Willis Towers Watson Public Limited Company (NASDAQ:WTW) Receives Average Rating of "Moderate Buy" from Brokerages

MarketBeat
30 days ago

Lazard, Inc. (NYSE:LAZ) Given Consensus Recommendation of "Hold" by Brokerages

MarketBeat
30 days ago

Ormat Technologies, Inc. (NYSE:ORA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

MarketBeat
30 days ago

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by Brokerages

MarketBeat
30 days ago

Ready Capital Corp (NYSE:RC) Given Consensus Rating of "Reduce" by Analysts

MarketBeat
30 days ago

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Brokerages

MarketBeat
30 days ago